Financhill
Buy
79

LENZ Quote, Financials, Valuation and Earnings

Last price:
$29.31
Seasonality move :
30.41%
Day range:
$28.51 - $29.78
52-week range:
$14.42 - $38.93
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
4.28x
Volume:
159.8K
Avg. volume:
210.8K
1-year change:
88.27%
Market cap:
$821.9M
Revenue:
--
EPS (TTM):
-$1.77

Earnings Data

Next earnings date for LENZ
Aug 14
2025
Most recent earnings per share
-$0.53
Missed by $0.21
(May 7/2025)
Consensus Estimate
-$0.32
(May 7/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

LENZ Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/14/2025 Q2 -- -- -- -$0.51 --
05/07/2025 Q1 -- -- -$0.53 -$0.32 -$0.21
03/19/2025 Q4 -- -- -$0.46 -$0.40 -$0.06
11/06/2024 Q3 -- -- -$0.38 -$0.43 $0.05
08/14/2024 Q2 -- -- -$0.40 -$0.67 $0.27
03/31/2024 Q1 -- -- -$3.53 -- --
12/31/2023 Q4 -- -- -$0.93 -- --
09/30/2023 Q3 -- -- -$0.74 -- --
03/31/2023 Q1 -- -- -$0.50 -- --
12/31/2022 Q4 -- -- -$0.37 -- --

LENZ Therapeutics Earnings Questions

  • How Much did LENZ Therapeutics Generate in Revenue Last Quarter?

    LENZ Therapeutics reported -- worth of top line sales in its most recent quarter.

  • Did LENZ Therapeutics Beat Earnings Last Quarter?

    LENZ Therapeutics announced earnings per share of -$0.53 which represents a miss of analyst forecast a -$0.32 per share.

  • Is LENZ Therapeutics Profitable?

    LENZ Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for LENZ Therapeutics EPS Next Year?

    LENZ Therapeutics's earnings are forecast to decrease from -$2.34 per share to -$2.52 per share next year representing a decrease of -7.69%.

  • When is LENZ Therapeutics's Earnings Date?

    LENZ Therapeutics's next earnings date is August 14, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will Salesforce Stock Be in 5 Years?
Where Will Salesforce Stock Be in 5 Years?

Salesforce (NYSE: CRM) just turned in a quarter that, on…

2 Ultra Safe Dividend Stocks to Buy Now
2 Ultra Safe Dividend Stocks to Buy Now

Historically, blue-chip dividend stocks have been good choices for periods…

Where Will Asana Stock Be in 5 Years?
Where Will Asana Stock Be in 5 Years?

Asana stock hasn’t given many investors on Wall Street any…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Sell
31
REGN alert for May 31

Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.

Buy
55
RGC alert for May 31

Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.

Sell
42
AMBA alert for May 31

Ambarella [AMBA] is down 15.13% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock